The Alzheimer's/Hearing Aid Paradox
In Search of Sanity
by
Book Details
About the Book
The facts are staggering. Scientific studies have shown that people with hearing loss have up to a five hundred percent higher risk of dementia (including Alzheimer’s), as well as serious falls and clinical depression. Today, around six million Americans have Alzheimer’s—a number that is only expected to increase and overwhelm the healthcare system in the next five to seven years.
In a groundbreaking presentation, Dr. Robert Keefer relies on thirty years of experience in the healthcare industry and the results of his meticulous research to offer insights on how to correct outdated Medicare policies, improve US hearing healthcare, and ensure well-performing hearing aids for everyone in need. After detailing why people with hearing loss don’t use hearing aids, he leads us on a journey into the world of these tiny medical devices, the US hearing healthcare matrix, the technology, and costs surrounding hearing aids, stories of those with hearing loss, wisdom from audiologists in their own words, and ways to advocate for changes that save hundreds of billions of dollars in healthcare expenses.
The Alzheimer’s/Hearing Aid Paradox shares insights and facts from a hearing aid industry insider that point the way to lowering the risk and cost of Alzheimer’s by providing hearing aids for everyone in need.
“With this book, the author has gifted us with a practical but ground-breaking way to reduce loneliness — and thus the risk of Alzheimer’s — by helping millions of Americans access high-performing hearing aids.”
—George Vradenburg ,Chairman and Co-Founder, UsAgainstAlzheimer’s
“This book presents a practical, no-nonsense way to better understand hearing loss and dementia and navigate hearing aid treatment options.”
—Dr. Brian Taylor ,Senior Director of Audiology, Signia Hearing, Editor of Audiology Practices, Co-Author of Fitting and Dispensing Hearing Aids, 3rd Edition
About the Author
Robert C. Keefer earned a PhD is in biochemistry from the University of Nebraska Medical School and has worked for over thirty years in the international medical device, pharmaceutical and diagnostics industries acquiring FDA product clearances and approvals, marketing and business development.